Wuhan Keqian Biology Co Ltd (688526) — Free Cash Flow Generation Index
Wuhan Keqian Biology Co Ltd (688526) has a Free Cash Flow Generation Index of 0.93x as of September 2025. Free cash flow of CN¥163.02 Million represents 1% of operating cash flow (CN¥174.36 Million). See working capital position of Wuhan Keqian Biology Co Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Wuhan Keqian Biology Co Ltd Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Wuhan Keqian Biology Co Ltd across 9 annual periods. Explore 688526 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year Free Cash Flow Generation Index for Wuhan Keqian Biology Co Ltd. For the full company profile including market capitalisation, see Wuhan Keqian Biology Co Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.73x | CN¥285.74 Million | CN¥392.68 Million | CN¥106.94 Million | ▼ -9.7% |
| 2023 | 0.81x | CN¥433.53 Million | CN¥538.03 Million | CN¥104.50 Million | ▲ +6.4% |
| 2022 | 0.76x | CN¥320.86 Million | CN¥423.71 Million | CN¥102.85 Million | ▲ +156.5% |
| 2021 | 0.30x | CN¥156.82 Million | CN¥531.27 Million | CN¥374.45 Million | ▼ -59.1% |
| 2020 | 0.72x | CN¥288.54 Million | CN¥400.14 Million | CN¥111.60 Million | ▲ +551.2% |
| 2019 | 0.11x | CN¥17.15 Million | CN¥154.89 Million | CN¥137.74 Million | ▼ -87.8% |
| 2018 | 0.91x | CN¥320.41 Million | CN¥351.83 Million | CN¥31.42 Million | ▲ +47.5% |
| 2017 | 0.62x | CN¥208.50 Million | CN¥337.61 Million | CN¥129.11 Million | ▼ -28.9% |
| 2016 | 0.87x | CN¥191.56 Million | CN¥220.69 Million | CN¥29.13 Million | — |